Patent · US Active

1-substituted 2-azabicyclo [3.1.1] heptyl derivatives useful as nicotinic acetylcholine receptor modulators for treating neurologic disorders

US8809365B2 · kind B2 · utility

0Cited by

7References

20Claims

0Family size

Assignee

UNIVERSITEIT GENT · BE

Inventors

Christian Stevens · Merelbeke, BE
Ann De Blieck · Ninove, BE
Thomas Heugebaert · Marke, BE

Key dates

Filing date	Nov 3, 2010
Grant date	Aug 19, 2014
Priority date	—
Expiry date	Jun 14, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention provides 2-azabicyclo[3.1.1]heptyl derivatives, and methods for producing them, which are useful therapeutic agents for preventing or treating central nervous system disorders and disease mediated by a Nicotinic Acetylcholine Receptor such as, but not limited to, Alzheimer's disease, Parkinson's disease, schizophrenia, epilepsy, dementia, pain and nicotine addiction.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.